This inventor holds 2 USPTO granted patents. Top assignees: Asta Medica, Aktiengesellschaft, Zentaris Ag. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Hilde Riethmüller-Winzen: Innovator in Fertility and Prostate Treatment
Introduction
Hilde Riethmüller-Winzen is a notable inventor based in Frankfurt-am-Main, Germany. She has made significant contributions to the fields of fertility treatment and prostate health. With a total of 2 patents, her work has the potential to impact many lives.
Latest Patents
Her latest patents include a method for the treatment of fertility disorders, which improves intrauterine insemination by utilizing luteinizing hormone-releasing hormone antagonists (LHRH antagonists). Additionally, she has developed a regime for treating prostate hypertrophy and prostate cancer, which employs Cetrorelix either alone or in combination with alpha-reductase inhibitors or alpha-receptor blocking agents. This innovative approach aims to reduce prostate volume while minimizing side effects associated with low testosterone levels.
Career Highlights
Throughout her career, Hilde has worked with prominent companies such as Asta Medica and Zentaris AG. Her expertise in the medical field has allowed her to develop groundbreaking treatments that address critical health issues.
Collaborations
Hilde has collaborated with esteemed colleagues, including Jürgen Engel and Thomas Reissmann, to further her research and innovations.
Conclusion
Hilde Riethmüller-Winzen's contributions to medical science, particularly in fertility and prostate health, showcase her dedication to improving patient outcomes. Her innovative patents reflect her commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile